LEE011
Drug
Novartis Pharma AG
Total Payments
$16,481
Transactions
3
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $16,481 | 3 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,091 | 1 | 61.2% |
| Travel and Lodging | $6,390 | 2 | 38.8% |
Top Doctors Receiving Payments for LEE011
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Medical Oncology | Dallas, TX | $16,481 | 3 |
Ad
Manufacturing Companies
- Novartis Pharma AG $16,481
Product Information
- Type Drug
- Total Payments $16,481
- Total Doctors 1
- Transactions 3
About LEE011
LEE011 is a drug associated with $16,481 in payments to 1 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2018 to 2018. In 2018, $16,481 was paid across 3 transactions to 1 doctors.
The most common payment nature for LEE011 is "Consulting Fee" ($10,091, 61.2% of total).